Indefinite Delivery Contract AG3A94C120001
- Not listed
- This indefinite delivery contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Biomerieux Inc., a global leader in in vitro diagnostics. The $640,000 single-award IDC facilitates the continued procurement of Biomerieux's specialized clinical diagnostic products and services to meet the FDA's testing needs. Under this IDC, Biomerieux has received a series of firm-fixed-price delivery orders to provide the FDA with a variety of its proprietary...
- This federal Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Biomerieux Inc. The contract has a ceiling value of $2,703,976 and a period of performance from July 2010 to July 2015. Biomerieux, through its Biomerieux, Inc. division, is a global leader in in vitro diagnostics and specializes in microbiological testing solutions. Under this IDC, Biomerieux is providing the FDA...
- This Indefinite Delivery Contract (IDC) with the ID N6264515D5052 was awarded by the Bureau of Medicine and Surgery, a Defense agency, to Biomerieux Inc. through its Biomerieux, Inc. Division. The contract, which does not involve any set-asides, has a ceiling value of $279,600 and was originally awarded on October 1, 2015, with a final completion date of September 30, 2020. The primary purpose of this IDC is to procure CPRR-Automated Blood Culture Analyzer and CPRR-Automated Microbiology...
- The federal contract IDV award is for the procurement of Vitek materials, reagents and supplies from Biomerieux Inc., a global leader in in vitro diagnostics. The prime contractor, Biomerieux Inc., is a foreign-owned, for-profit manufacturer of diagnostic equipment, reagents and consumables. The Defense Health Agency (DHA), which oversees healthcare support for all U.S. military branches and beneficiaries, issued this single-award, indefinite delivery contract with a potential value of...
- This indefinite delivery contract was awarded by the Department of the Army Medical Command to Biomerieux Inc., a global leader in in vitro diagnostics and microbiology testing solutions. The contract has a potential value of $3,115,077.60 and facilitates the continued procurement of Biomerieux's proprietary clinical diagnostic platforms, reagents, and services to meet federal testing needs. The task orders issued to date have been for the company's SENSI CARD product, a firm-fixed-price,...
- The key details of this federal contract IDV award are as follows: The Defense Health Agency, a component of the U.S. Department of Defense, awarded a single-award Indefinite Delivery Contract (IDC) to Biomerieux Inc., a manufacturer of in vitro diagnostic solutions, for the provision of microbiology analyzer equipment, supplies, and related services. The contract has a ceiling value of $1,135,577.95 and a period of performance from October 1, 2020 through September 30, 2025. Biomerieux will...
- This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Army Medical Command (MEDCOM) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at up to $1,501,969.18, is for the supply of microbial identification (ID) and antibiotic susceptibility testing (AST) cards and reagents to support infectious disease testing and pathogen detection across government healthcare operations. The contract includes multiple delivery orders issued from October 2017...
- This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Medical Command agency, a defense agency, to Biomerieux Inc. through its Biomerieux, Inc. division. The IDV has a total ceiling value of $213,110 and a period of performance through September 30, 2020. Under this single-award IDV, the agency has issued multiple firm-fixed-price delivery orders for an "Automated Nucleic Acid Extraction System," with a total value of $43,310 per order. The place of performance for...
- This federal contract IDV award to Biomerieux Inc., a global leader in in vitro diagnostics, is for the delivery of Campylobacter detection kits and related microbial testing solutions to support infectious disease testing and pathogen detection across various government healthcare operations. The contract, awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, has a ceiling value of $955,000 and a period of performance through June 2026. It was...
- This federal contract Indefinite Delivery Contract (IDC) was awarded by the U.S. Navy Bureau of Medicine and Surgery (BUMED), a defense agency, to Biomerieux Inc. through its Biomerieux, Inc. division. The contract has a ceiling value of $95,235 and a period of performance ending on September 30, 2020. Under this IDC, Biomerieux is providing its proprietary "Cost per Reportable Result (CPRR) Automated Blood Culture Analyzer" systems, reagents, and associated maintenance services to...
- AG3A94C120001Indefinite Delivery Contract
- 4Federal Contract Awards
The federal contract IDV was awarded by the U.S. federal agency Office of Administrative Services Procurement Management Branch, a civilian agency, to Biomerieux Inc., a for-profit manufacturer of in vitro diagnostic and microbiological testing solutions. The $63,698.40 single-award IDC contract provides a BIOMERIEUX MAINTENANCE AGREEMENT for the EL, FERN, MWL, and WL diagnostic platforms from April 1, 2012 to March 31, 2013 under the program acronym AGYV. No set-asides were used for this award. The IDC has generated several task orders, including a $37,421.86 BIOMERIEUX MA for the EL and WL platforms through October 2016, a $12,210.30 order to repair VIDAS equipment through May 2015, and two $101,627.64 and $86,399.46 BIOMERIEUX MA orders for the EL, MWL, and WL platforms through April 2014 and May 2013, respectively. All task orders were firm-fixed-price delivery orders with no set-asides, indicating Biomerieux is likely considered a sole-source provider of these specialized diagnostic platforms and services to the agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 5 | Other Administrative Action | $0 | 4/13/15 | |
| 4 | Exercise an Option | $0 | 3/19/14 | |
| 3 | Other Administrative Action | $0 | 3/25/13 | |
| 2 | Exercise an Option | $0 | 3/19/13 | |
| 1 | Funding Only Action | ($2k) | 5/3/12 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order AG3A94C120001-AG3A94D140050 | Biomerieux Inc. | $101.6k | 4/9/14 | 4/30/15 | 1/26/18 | |
Delivery Order AG3A94C120001-AG3A94D140065 | Biomerieux Inc. | $12.2k | 5/13/14 | 5/12/15 | 1/9/18 | |
Delivery Order AG3A94C120001-AG3A94D150068 | Biomerieux Inc. | $37.4k | 5/4/15 | 10/31/16 | 5/4/15 | |
Delivery Order AG3A94C120001-AG3A94D130073 | Biomerieux Inc. | $86.4k | 4/16/13 | 5/16/13 | 4/16/13 |